Kenvue Brands Drug Patent Portfolio
Kenvue Brands owns 9 orange book drugs protected by 17 US patents with Children'S Motrin Cold having the least patent protection, holding only 1 patent. And Pepcid Ac with maximum patent protection, holding 6 patents. Given below is the list of Kenvue Brands's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7014867 | Tablet comprising cetirizine and pseudoephedrine | 10 Jun, 2022 | Expired |
| US7226614 | Tablet comprising cetirizine and pseudoephedrine | 10 Jun, 2022 | Expired |
| US6814978 | Process for preparing a soft tablet | 26 Feb, 2022 | Expired |
| US6814978 | Process for preparing a soft tablet | 26 Aug, 2021 | Expired |
| US6469009 | Pharmaceutical compositions for the treatment of rhinitis | 13 Jul, 2019 | Expired |
| US6211246 | Rapidly absorbed liquid compositions | 10 Jun, 2019 | Expired |
| US6946120 | Pharmaceutical composition | 20 Apr, 2019 | Expired |
| US6455533 | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin | 02 Jul, 2018 | Expired |
| US6103260 | Simethicone/anhydrous calcium phosphate compositions | 17 Jul, 2017 | Expired |
| US5854267 | Method for preventing heartburn | 29 Jun, 2016 | Expired |
| US6489329 | Pharmaceutical compositions for the treatment of rhinitis | 08 Apr, 2016 | Expired |
| US5989588 | Methods and compositions for preventing and treating heartburn | 30 Mar, 2016 | Expired |
| US5854267 | Method for preventing heartburn | 29 Dec, 2015 | Expired |
| US5667794 | Heartburn treatment | 02 Nov, 2015 | Expired |
| US5989588 | Methods and compositions for preventing and treating heartburn | 30 Sep, 2015 | Expired |
| US5667794 | Heartburn treatment | 02 May, 2015 | Expired |
| US5229137 | Methods and pharmaceutical compositions for treating episodic heartburn | 16 Nov, 2012 | Expired |
Latest Legal Activities on Kenvue Brands's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Kenvue Brands.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 22 Nov, 2018 | US7226614 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 07 Sep, 2017 | US7014867 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 05 Jun, 2007 | US7226614 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 05 Jun, 2007 | US7226614 |
|
Issue Notification Mailed
Critical
| 16 May, 2007 | US7226614 |
| Dispatch to FDC | 07 May, 2007 | US7226614 |
|
Application Is Considered Ready for Issue
Critical
| 01 May, 2007 | US7226614 |
|
Issue Fee Payment Received
Critical
| 25 Apr, 2007 | US7226614 |
|
Issue Fee Payment Verified
Critical
| 25 Apr, 2007 | US7226614 |
|
Correspondence Address Change
Critical
| 11 Apr, 2007 | US6946120 |
|
Mail Notice of Allowance
Critical
| 06 Apr, 2007 | US7226614 |
|
Notice of Allowance Data Verification Completed
Critical
| 03 Apr, 2007 | US7226614 |
|
PARALEGAL OR ELECTRONIC TERMINAL DISCLAIMER APPROVED
Critical
| 02 Apr, 2007 | US7226614 |
| Date Forwarded to Examiner | 12 Mar, 2007 | US7226614 |
|
Response after Non-Final Action
Critical
| 26 Feb, 2007 | US7226614 |
Kenvue Brands's Drug Patent Litigations
Kenvue Brands's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Mar 30, 2001, against patent number US6469009. The petitioner , challenged the validity of this patent, with VAN DE VENNE et al as the respondent. Click below to track the latest information on how companies are challenging Kenvue Brands's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US6469009 | March, 2001 |
Decision
(11 Jul, 2002)
| VAN DE VENNE et al | |
Kenvue Brands's Family Patents
Kenvue Brands Drug List
Given below is the complete list of Kenvue Brands's drugs and the patents protecting them.
1. Children's Motrin Cold
Children's Motrin Cold is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6211246 | Rapidly absorbed liquid compositions |
10 Jun, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Motrin Cold's drug page
2. Children's Zyrtec Allergy
Children's Zyrtec Allergy is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6455533 | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
02 Jul, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Zyrtec Allergy's drug page
3. Children's Zyrtec Hives Relief
Children's Zyrtec Hives Relief is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6455533 | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
02 Jul, 2018
(6 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Children's Zyrtec Hives Relief's drug page
4. Imodium Multi-symptom Relief
Imodium Multi-symptom Relief is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6103260 | Simethicone/anhydrous calcium phosphate compositions |
17 Jul, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Imodium Multi-symptom Relief's drug page
5. Men's Rogaine
Men's Rogaine is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6946120 | Pharmaceutical composition |
20 Apr, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Men's Rogaine's drug page
Explore Our Curated Drug Screens
6. Pepcid Ac
Pepcid Ac is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6814978
(Pediatric)
| Process for preparing a soft tablet |
26 Feb, 2022
(2 years ago)
| Expired |
| US6814978 | Process for preparing a soft tablet |
26 Aug, 2021
(3 years ago)
| Expired |
| US5854267
(Pediatric)
| Method for preventing heartburn |
29 Jun, 2016
(8 years ago)
| Expired |
| US5854267 | Method for preventing heartburn |
29 Dec, 2015
(9 years ago)
| Expired |
| US5667794
(Pediatric)
| Heartburn treatment |
02 Nov, 2015
(9 years ago)
| Expired |
| US5667794 | Heartburn treatment |
02 May, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pepcid Ac's drug page
7. Pepcid Complete
Pepcid Complete is protected by 5 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6814978
(Pediatric)
| Process for preparing a soft tablet |
26 Feb, 2022
(2 years ago)
| Expired |
| US6814978 | Process for preparing a soft tablet |
26 Aug, 2021
(3 years ago)
| Expired |
| US5989588
(Pediatric)
| Methods and compositions for preventing and treating heartburn |
30 Mar, 2016
(8 years ago)
| Expired |
| US5989588 | Methods and compositions for preventing and treating heartburn |
30 Sep, 2015
(9 years ago)
| Expired |
| US5229137
(Pediatric)
| Methods and pharmaceutical compositions for treating episodic heartburn |
16 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Pepcid Complete's drug page
8. Women's Rogaine
Women's Rogaine is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6946120 | Pharmaceutical composition |
20 Apr, 2019
(5 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Women's Rogaine's drug page
9. Zyrtec-d 12 Hour
Zyrtec-d 12 Hour is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US7014867 | Tablet comprising cetirizine and pseudoephedrine |
10 Jun, 2022
(2 years ago)
| Expired |
| US7226614 | Tablet comprising cetirizine and pseudoephedrine |
10 Jun, 2022
(2 years ago)
| Expired |
| US6469009 | Pharmaceutical compositions for the treatment of rhinitis |
13 Jul, 2019
(5 years ago)
| Expired |
| US6489329 | Pharmaceutical compositions for the treatment of rhinitis |
08 Apr, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zyrtec-d 12 Hour's drug page